June 24, 2022

Omicron patients under 60 can take paracetamol, expert says


People under the age of 60 without comorbidities, infected with the Omicron variant of Covid-19, can start their treatment with paracetamol, said Maharashtra Covid task force member Dr Shashank Joshi.

In the latest episode of Heal Foundation’s Health4All online show, Joshi, an endocrinologist at Lilavati Hospital in Mumbai, said doctors are likely to prescribe antivirals like molnupiravir, if someone over 50 has a constant fever for two days alongside two or three comorbidities.



But “Omicron patients under 60 without comorbidities can start symptomatic treatment with paracetamol,” he said.

However, paracetamol should not be prescribed to children under 18, pregnant women or patients requiring hospitalization, he added.

Earlier, there were reports claiming 500mg paracetamol tablets were being given to children along with Covaxin – the only Covid vaccine approved for adolescents in India.

Vaccine maker Bharat Biotech clarified that paracetamol or painkillers are not recommended for adolescents after being vaccinated with Covaxin.

In addition, Joshi recommended using paracetamol within 72 hours of symptom onset “for patients in the high-risk population group, i.e., hypertensives, diabetics, people on immunosuppressed medications, the elderly , people suffering from other ailments and the like”.

“Whenever we have a new disease that is constantly evolving, new methods of treatment are also inevitable. However, it is up to doctors to identify those most vulnerable and prescribe drugs accordingly,” he said. added.

–IANS

RVT/sks

(Only the title and image of this report may have been edited by Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear reader,

Business Standard has always endeavored to provide up-to-date information and commentary on developments that matter to you and that have wider political and economic implications for the country and the world. Your constant encouragement and feedback on how to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these challenging times stemming from Covid-19, we remain committed to keeping you informed and updated with credible news, authoritative opinions and incisive commentary on relevant topical issues.
However, we have a request.

As we battle the economic impact of the pandemic, we need your support even more so that we can continue to bring you more great content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of bringing you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism we are committed to.

Support quality journalism and subscribe to Business Standard.

digital editor